相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
Seok Jong Chung et al.
PARKINSONISM & RELATED DISORDERS (2019)
The Cardiometabolic Risk Profile of Young Adults With Diabetes in the US
Sharon H. Saydah et al.
DIABETES CARE (2019)
Mechanism of the neuroprotective effect of GLP-1 in a rat model of Parkinson's with pre-existing diabetes
Eman A. Elbassuoni et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease A Secondary Analysis of the Exenatide-PD Trial
Dilan Athauda et al.
JAMA NEUROLOGY (2019)
Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study
Yuanchi Hui et al.
ENDOCRINE (2019)
The Parkinson's phenome-traits associated with Parkinson's disease in a broadly phenotyped cohort
Karl Heilbron et al.
NPJ PARKINSONS DISEASE (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
Ivan Martinez-Valbuena et al.
ACTA NEUROPATHOLOGICA (2018)
Striatal synapses, circuits, and Parkinson's disease
Shenyu Zhai et al.
CURRENT OPINION IN NEUROBIOLOGY (2018)
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
Yu-Wen Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View
Alice Biosa et al.
MOLECULAR NEUROBIOLOGY (2018)
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease
Seung Pil Yun et al.
NATURE MEDICINE (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Diabetes mellitus and Parkinson disease
Gennaro Pagano et al.
NEUROLOGY (2018)
Association between diabetes and subsequent Parkinson disease A record-linkage cohort study
Eduardo De Pablo-Fernandez et al.
NEUROLOGY (2018)
Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
Dilan Athauda et al.
NEUROPHARMACOLOGY (2018)
Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?
Ana Marques et al.
PARKINSONISM & RELATED DISORDERS (2018)
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease
Annekatrin Koenig et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
Norlinah Mohamed Ibrahim et al.
MOVEMENT DISORDERS (2018)
Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies?
Guadalupe Vidal-Martinez et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Prevalence of Parkinson's disease across North America
C. Marras et al.
NPJ PARKINSONS DISEASE (2018)
A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease
Ziyue Yuan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
Ramon Cacabelos
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain
Kymry T. Jones et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda et al.
LANCET (2017)
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Yu-Wan Yang et al.
MEDICINE (2017)
Glitazone Use Associated With Reduced Risk of Parkinson's Disease
Brage Brakedal et al.
MOVEMENT DISORDERS (2017)
A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway
Dong Seok Kim et al.
CELL TRANSPLANTATION (2017)
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases
Aree Witoelar et al.
JAMA NEUROLOGY (2017)
A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model
Lijuan Shi et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
M. Petrou et al.
ACADEMIC RADIOLOGY (2016)
A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF
Chenhui Ji et al.
BRAIN RESEARCH (2016)
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
Caterina Palleria et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2016)
Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance
Ming Lu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies
Xuejing Yue et al.
MEDICINE (2016)
Glycation in Parkinson's Disease and Alzheimer's Disease
Hugo Vicente Miranda et al.
MOVEMENT DISORDERS (2016)
Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model
Yanwei Li et al.
NEUROPHARMACOLOGY (2016)
A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain
Lijun Cao et al.
NEUROREPORT (2016)
Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease
Istvan Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Insulin resistance and Parkinson's disease: A new target for disease modification?
D. Athauda et al.
PROGRESS IN NEUROBIOLOGY (2016)
Thiazolidinediones and Parkinson Disease: A Cohort Study
John G. Connolly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity
Claudia A. Grillo et al.
DIABETES (2015)
Eating High Fat Chow Decreases Dopamine Clearance in Adolescent and Adult Male Rats but Selectively Enhances the Locomotor Stimulating Effects of Cocaine in Adolescents
Michelle G. Baladi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. (vol 14, pg 795, 2015)
Chadwick W. Christine
LANCET NEUROLOGY (2015)
Type 2 diabetes mellitus and biomarkers of neurodegeneration
Chris Moran et al.
NEUROLOGY (2015)
DYSREGULATION OF PARKIN IN THE SUBSTANTIA NIGRA OF DB/DB AND HIGH-FAT DIET MICE
R. Khang et al.
NEUROSCIENCE (2015)
NEUROPROTECTIVE EFFECTS OF LIXISENATIDE AND LIRAGLUTIDE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
W. Liu et al.
NEUROSCIENCE (2015)
Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
Andre Kleinridders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward
Melissa A. Stouffer et al.
NATURE COMMUNICATIONS (2015)
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study
Ruth Brauer et al.
PLOS MEDICINE (2015)
GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats
Ajaykumar N. Sharma et al.
METABOLIC BRAIN DISEASE (2015)
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni et al.
LANCET NEUROLOGY (2015)
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson's Disease
Iciar Aviles-Olmos et al.
JOURNAL OF PARKINSONS DISEASE (2014)
First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease
Christian Hoelscher
ALZHEIMERS & DEMENTIA (2014)
The Ability of Insulin To Inhibit the Formation of Amyloid by Pro-Islet Amyloid Polypeptide Processing Intermediates Is Significantly Reduced in the Presence of Sulfated Glycosaminoglycans
Hui Wang et al.
BIOCHEMISTRY (2014)
Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
Ling Wang et al.
EXPERIMENTAL NEUROLOGY (2014)
Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases
Shan Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress
Mohit K. Sharma et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
Laura Dunn et al.
NEUROBIOLOGY OF AGING (2014)
Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates
Christine Swanson et al.
NEUROLOGICAL RESEARCH (2014)
INSULIN RESISTANCE AND GRAY MATTER VOLUME IN NEURODEGENERATIVE DISEASE
J. K. Morris et al.
NEUROSCIENCE (2014)
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study
Martina Giuntini et al.
PARKINSONISM & RELATED DISORDERS (2014)
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
Nicolaas I. Bohnen et al.
PARKINSONISM & RELATED DISORDERS (2014)
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lin Lu et al.
PLOS ONE (2014)
Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain
Zhihong Chen et al.
NATURE COMMUNICATIONS (2014)
Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study
Edward W. Gregg et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Parkinson's disease, insulin resistance and novel agents of neuroprotection
Iciar Aviles-Olmos et al.
BRAIN (2013)
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
Venus Thomanetz et al.
JOURNAL OF CELL BIOLOGY (2013)
Exenatide and the treatment of patients with Parkinson's disease
Iciar Aviles-Olmos et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
Caitriona M. Long-Smith et al.
NEUROMOLECULAR MEDICINE (2013)
Diabetes is associated with postural instability and gait difficulty in Parkinson disease
Vikas Kotagal et al.
PARKINSONISM & RELATED DISORDERS (2013)
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Brian Finan et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Shared dysregulated pathways lead to Parkinson's disease and diabetes
Jose A. Santiago et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
Alastair J. Noyce et al.
ANNALS OF NEUROLOGY (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat
Amjad Abuirmeileh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Domenico Bosco et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from Sweden
Xinjun Li et al.
NEURODEGENERATIVE DISEASES (2012)
Clinical features of Parkinson disease when onset of diabetes came first A case-control study
E. Cereda et al.
NEUROLOGY (2012)
Diabetes and Risk of Parkinson's Disease A systematic review and meta-analysis
Emanuele Cereda et al.
DIABETES CARE (2011)
Diabetes and the Risk of Developing Parkinson's Disease in Denmark
Eva Schernhammer et al.
DIABETES CARE (2011)
Diabetes and Risk of Parkinson's Disease
Qun Xu et al.
DIABETES CARE (2011)
Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels
Jyoti C. Patel et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Obesity, Diabetes, and Risk of Parkinson's Disease
Natalia Palacios et al.
MOVEMENT DISORDERS (2011)
Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis
R. Fan et al.
DIABETES OBESITY & METABOLISM (2010)
Epidemiology of Type 1 Diabetes
David M. Maahs et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
[C-11]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
A. L. Bartels et al.
PARKINSONISM & RELATED DISORDERS (2010)
Synaptic plasticity, dopamine and Parkinsons disease: one step ahead
Paolo Calabresi et al.
BRAIN (2009)
The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis
Shaodong Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Autoimmune disease and risk for Parkinson disease A population-based case-control study
K. Rugbjerg et al.
NEUROLOGY (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation
Xiaocheng C. Dong et al.
CELL METABOLISM (2008)
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver et al.
DIABETES CARE (2008)
Glucagon-like peptide I receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
Alexander Harkavyi et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Anthony H. V. Schapira
LANCET NEUROLOGY (2008)
Peripheral inflammatory biomarkers and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells
Sangeeta Ghosh et al.
MOLECULAR PHARMACOLOGY (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
Randy L. Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Insulin and the insulin receptor in experimental models of learning and memory
WQ Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Insulin and neurodegenerative disease: shared and specific mechanisms
S Craft et al.
LANCET NEUROLOGY (2004)
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity
WD Yao et al.
NEURON (2004)
Pancreatic β-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation
ETAS Jaikaran et al.
BIOCHEMICAL JOURNAL (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons
M Passafaro et al.
NATURE NEUROSCIENCE (2001)
分享论文
